Sagimet Biosciences Inc (SGMT)
4.06
+0.14
(+3.57%)
USD |
NASDAQ |
Apr 26, 16:00
4.07
+0.01
(+0.25%)
After-Hours: 20:00
Sagimet Biosciences Market Cap: 129.57M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 129.57M |
| April 25, 2024 | 125.10M |
| April 24, 2024 | 133.08M |
| April 23, 2024 | 136.59M |
| April 22, 2024 | 128.61M |
| April 19, 2024 | 127.97M |
| April 18, 2024 | 126.70M |
| April 17, 2024 | 129.89M |
| April 16, 2024 | 133.40M |
| April 15, 2024 | 145.53M |
| April 12, 2024 | 154.14M |
| April 11, 2024 | 166.59M |
| April 10, 2024 | 161.48M |
| April 09, 2024 | 169.46M |
| April 08, 2024 | 171.70M |
| April 05, 2024 | 169.46M |
| April 04, 2024 | 173.93M |
| April 03, 2024 | 173.29M |
| April 02, 2024 | 167.23M |
| April 01, 2024 | 166.91M |
| March 28, 2024 | 172.97M |
| March 27, 2024 | 182.87M |
| March 26, 2024 | 166.91M |
| March 25, 2024 | 166.59M |
| March 22, 2024 | 143.93M |
| Date | Value |
|---|---|
| March 21, 2024 | 148.40M |
| March 20, 2024 | 145.53M |
| March 19, 2024 | 142.97M |
| March 18, 2024 | 128.29M |
| March 15, 2024 | 128.93M |
| March 14, 2024 | 137.87M |
| March 13, 2024 | 148.32M |
| March 12, 2024 | 159.16M |
| March 11, 2024 | 174.79M |
| March 08, 2024 | 183.40M |
| March 07, 2024 | 205.73M |
| March 06, 2024 | 212.75M |
| March 05, 2024 | 192.97M |
| March 04, 2024 | 199.35M |
| March 01, 2024 | 192.01M |
| February 29, 2024 | 195.52M |
| February 28, 2024 | 203.81M |
| February 27, 2024 | 235.71M |
| February 26, 2024 | 229.65M |
| February 23, 2024 | 211.15M |
| February 22, 2024 | 214.66M |
| February 21, 2024 | 214.98M |
| February 20, 2024 | 222.63M |
| February 16, 2024 | 240.81M |
| February 15, 2024 | 276.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
51.06M
Minimum
Nov 13 2023
421.74M
Maximum
Jan 22 2024
194.85M
Average
171.70M
Median
Apr 08 2024
Market Cap Benchmarks
| Madrigal Pharmaceuticals Inc | 3.847B |
| 89bio Inc | 786.56M |
| Viking Therapeutics Inc | 8.194B |
| Akero Therapeutics Inc | 1.361B |
| Arrowhead Pharmaceuticals Inc | 2.741B |
Market Cap Related Metrics
| Price to Book Value | 1.423 |
| Price | 4.06 |
| Earnings Yield | -32.24% |